Sanaz Gabery

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 3

Top Topics

Placebo Controlled

Top Venues

Clinical endocrinology

This page only lists publications with an associated author ORCID identifier.

Publications

Wei-Qing Wang, Stephen C Bain, Fang Bian, Rui Chen, Sanaz Gabery, Shan Huang, Thomas Bo Jensen, Bifen Luo, Guoyue Yuan, Yanqiu Wang, null null
Efficacy and safety of oral semaglutide monotherapy vs placebo in a predominantly Chinese population with type 2 diabetes (PIONEER 11): a double-blind, Phase IIIa, randomised trial. Diabetologia (2024)
Xiantong Zou, Rikke Mette Agesen, Stephen C Bain, Fangming Fu, Sanaz Gabery, Jianlin Geng, Yiming Li, Yibing Lu, Bifen Luo, Wuyan Pang, Yi Tao, null null
Efficacy and safety of oral semaglutide vs sitagliptin in a predominantly Chinese population with type 2 diabetes uncontrolled with metformin: PIONEER 12, a double-blind, Phase IIIa, randomised trial. Diabetologia (2024)
Sigridur Fjalldal, Lars Rylander, Danielle van Westen, Helene Holmer, Cecilia Follin, Sanaz Gabery, Åsa Petersén, Eva Marie Erfurth
Brain white matter lesions are associated with reduced hypothalamic volume and cranial radiotherapy in childhood-onset craniopharyngioma. Clinical endocrinology 94 (1) (2020)